Live feed
Filing
SC 13D
SC 13D0001085037-21-000041·MAINPOINTE PHARMACEUTICALS, LLC
Schedule 13D ownership disclosure
REPLICEL LIFE SCIENCES INC.
Security class unavailable · CUSIP: 76027P400
Event date: 2021-04-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,506,802
- Percent of class
- 6.7700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085037-21-000041
- Form type
- SC 13D
- Filer
- MAINPOINTE PHARMACEUTICALS, LLC
- CIK
- CIK 1864509
- Filed
- Jun 04, 2021
- Reporting period
- Apr 23, 2021
- Description
- Schedule 13D beneficial ownership